Bouchoucha Michel, Devroede Ghislain, Faye Alain, Arsac Michel
Laboratoire de Physiologie Digestive et Service de Chirurgie, Hôpital Laennec, 42 rue de Sèvres, 75007 Paris, France.
Int J Colorectal Dis. 2002 Nov;17(6):412-7; discussion 418-9. doi: 10.1007/s00384-002-0428-1. Epub 2002 Sep 4.
Fecal incontinence is common. The potential contribution of colon function to continence has not been studied. Treatment is poorly codified. To evaluate colonic transit time (CTT) and its importance in the management of fecal incontinence we analyzed in a retrospective study the CTT in patients with fecal incontinence, and on this basis in a prospective study used a treatment algorithm taking colonic transit into account.
We studied 30 healthy subjects and 171 patients (110 in the retrospective and 61 in the prospective study). Anorectal manometry and CTT measurement using radio-opaque markers were performed. Patients were divided into three groups according to their CTT: rapid (<24 h), normal, and delayed (>65 h). In patients with abnormal CTT modifiers of transit time were used as first line of treatment. Biofeedback therapy was used alone in patients with normal transit and used in the other patients after 6 weeks of medication when there was no or only partial improvement.
Incontinent patients had less upper and lower anal pressure and maximal squeeze pressure and longer CTT than controls. Rapid and delayed transit times were found, respectively, in 17% and 32% of patients. After 6 weeks of treatment 77% of patients had recovered from fecal incontinence. Biofeedback therapy increased total improvement to 95%.
We conclude that evaluation of CTT is useful in the management of fecal incontinence, and that medical therapy is sufficient to treat most incontinent patients. This implies the use of a careful selection algorithm prior to surgery for fecal incontinence.
大便失禁很常见。结肠功能对控便的潜在作用尚未得到研究。治疗方法尚无明确规范。为评估结肠传输时间(CTT)及其在大便失禁管理中的重要性,我们在一项回顾性研究中分析了大便失禁患者的CTT,并在此基础上在一项前瞻性研究中采用了一种考虑结肠传输的治疗算法。
我们研究了30名健康受试者和171例患者(回顾性研究110例,前瞻性研究61例)。进行了肛门直肠测压和使用不透X线标志物测量CTT。根据CTT将患者分为三组:快速传输组(<24小时)、正常传输组和延迟传输组(>65小时)。对于CTT异常的患者,使用传输时间调节剂作为一线治疗。传输正常的患者单独使用生物反馈疗法,其他患者在药物治疗6周后若没有改善或只有部分改善则使用生物反馈疗法。
失禁患者的肛门上下压力和最大挤压压力均低于对照组,且CTT比对照组更长。分别有17%和32%的患者存在快速和延迟传输时间。治疗6周后,77%的患者大便失禁症状得到缓解。生物反馈疗法使总体改善率提高到95%。
我们得出结论,CTT评估在大便失禁的管理中是有用的,并且药物治疗足以治疗大多数失禁患者。这意味着在大便失禁手术前应使用仔细的选择算法。